Mouse anti-human PIWIL2 mAb
Scientists at the University of Göttingen generated polyklonal and monoclonal antibodies against the new diagnostic tumor marker PIWIL2. The tumor marker PIWIL2 is not present in normal cells (other than testicular), not present in inflammtory tissues but present in almost all cancer cell types. Because of its important role in tumor genesis and therefor early detection of tumors it could be used for first line screening. Monoclonal antibodies against PIWIL2 could be used for tissue analysis in surgery in clinics, detection of PIWIL2 in blood samples (ELISA) and monitoring of reponse to cancer treatment. Furthermore the antibodies could be used for targeting PIWIL2 within a cancer therapy.
Further Information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-151
Contact
Dr. Jens-Peter Horst
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Time to Leave Home? Revealed Insights into Brood Care of Cichlids
Shell-dwelling cichlids take intense care of their offspring, which they raise in abandoned snail shells. A team at the Max Planck Institute for Biological Intelligence used 3D-printed snail shells to…
Smart Fabrics: Innovative Comfortable Wearable Tech
Researchers have demonstrated new wearable technologies that both generate electricity from human movement and improve the comfort of the technology for the people wearing them. The work stems from an…
Going Steady—Study Reveals North Atlantic’s Gulf Stream Remains Robust
A study by the University of Bern and the Woods Hole Oceanographic Institution in the USA concludes that the ocean circulation in the North Atlantic, which includes the Gulf Stream,…